Bank of Montreal’s Armata Pharmaceuticals ARMP Stock Holding History

Bank of Montreal’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,444	Closed	-$11K	–	3714
2021 Q1	$11K	Hold	2,444	–	–	﹤0.01%	4310
2020 Q4	$9K	Hold	2,444	–	–	﹤0.01%	4667
2020 Q3	$8K	Hold	2,444	–	–	﹤0.01%	4213
2020 Q2	$10K	Hold	2,444	–	–	﹤0.01%	4152
2020 Q1	$8K	Hold	2,444	–	–	﹤0.01%	3548
2019 Q4	$8K	Hold	2,444	–	–	﹤0.01%	4613
2019 Q3	$9K	Hold	2,444	–	–	﹤0.01%	4443
2019 Q2	$10K	Sell	2,444 -1	-0%	-$4	﹤0.01%	4513
2019 Q1	$10K	Hold	2,445	–	–	﹤0.01%	3865
2018 Q4	$7K	Buy	2,445 +1,731	+242%	+$8.44K	﹤0.01%	3973
2018 Q3	$10K	Hold	714	–	–	﹤0.01%	3917
2018 Q2	$11K	Hold	714	–	–	﹤0.01%	3926
2018 Q1	$11K	Buy	+714	New	+$12.7K	﹤0.01%	3721

Other funds holding ARMP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

SWM

SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's ARMP Position: Q2 2021 in Review

Bank of Montreal sold out of Armata Pharmaceuticals (ARMP) in Q2 2021, closing a stake of 2,444 shares — an estimated $11K sold.

Bank of Montreal first reported a position in ARMP in Q1 2018 and held it in 13 quarters. The position peaked at $11K in Q1 2021. 21 funds tracked by Wall St. Rank hold ARMP as of Q2 2021.

Bank of Montreal reported no remaining Armata Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 2,444 Armata Pharmaceuticals shares in Q2 2021, an estimated $11K.
Bank of Montreal first reported a position in Armata Pharmaceuticals in Q1 2018 and held it in 13 quarters.
Bank of Montreal's Armata Pharmaceuticals position peaked at $11K in Q1 2021.
21 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.